Patent details

Basic Information

Publication number:

EP2205279

PCT Application Number:

PCT/US/2008/077417

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088358932

PCT Publication Number:

WO/2009/045796

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN

French Title of Invention:

COMBINAISON PHARMACEUTIQUE D'ALISKIRÈNE ET DE VALSARTANE

German Title of Invention:

PHARMAZEUTISCHE KOMBINATION AUS ALISKIREN UND VALSARTAN

SPC Number:

Dates

Filing date:

24/09/2008

Grant date:

13/04/2011

EP Publication Date:

13/04/2011

PCT Publication Date:

09/04/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/07/2010

EP B1 Publication Date:

13/04/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/09/2011

Expiration date:

24/09/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/09/2008

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

SCHLÜTERMANN Burkhard

Address:

Germany (DE)

2

Name:

LI Shoufeng

Address:

United States (US)

3

Name:

GERBER Frédéric

Address:

France (FR)

4

Name:

CURDY Catherine

Address:

Switzerland (CH)

5

Name:

BECKER Dieter

Address:

Germany (DE)

Priority

Priority Number:

975905 P

Priority Date:

28/09/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 45/06;

Filing date	Document type	Number of pages